UP!
| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q3 2022 | 2022-10-31 | Future report Set alerts | |
| Q2 2022 | 2022-08-08 | 0.13 | 0.13 |
| Q1 2022 | 2022-05-10 | -0.12 | -0.12 |
| Q4 2021 | 2022-03-15 | 0.54 | 0.54 |
| Q3 2021 | 2021-11-01 | 1.01 | 1.01 |
| Q2 2021 | 2021-08-06 | 0.67 | 0.67 |
| Q1 2021 | 2021-05-07 | 1.04 | 1.04 |
| Q4 2020 | 2021-03-09 | 0.80 | 0.80 |
| Q3 2020 | 2020-11-05 | 0.97 | 0.97 |
| Q2 2020 | 2020-08-06 | 0.69 | 0.69 |
| 2016-07-10 | Downgrade | Oppenheimer Holdings Inc. | Outperform | |
| 2016-07-08 | Downgrade | Citigroup Inc. | Outperform to Market Perform | $49.00 |
| 2016-06-22 | Initiated Coverage | Raymond James | Strong-Buy | $68.00 |
| 2016-06-22 | Initiated Coverage | Raymond James Financial Inc. | Strong-Buy | $68.00 |
| 2016-06-17 | Reiterated Rating | Guggenheim | Buy | $55.00 to $65.00 |
| 2016-05-24 | Downgrade | Standpoint Research | Buy to Hold | |
| 2016-05-07 | Reiterated Rating | Guggenheim | Buy | $50.00 to $55.00 |
| 2016-05-03 | Reiterated Rating | Oppenheimer | Buy | |
| 2016-05-03 | Reiterated Rating | Oppenheimer Holdings Inc. | Buy | |
| 2016-04-13 | Reiterated Rating | Oppenheimer | Buy | $47.00 to $49.00 |
| 2015-11-13 | Initiated Coverage | Standpoint Research | Buy | $54.00 |
| 2015-11-04 | Reiterated Rating | Roth Capital | Buy | $60.00 to $56.00 |
| 2015-11-04 | Lower Price Target | Oppenheimer | $55.00 to $50.00 | |
| 2015-10-09 | Lower Price Target | Oppenheimer | Outperform | $65.00 to $55.00 |
| 2015-09-28 | Upgrade | Roth Capital | Neutral to Buy | $67.00 to $60.00 |
| 2015-08-04 | Lower Price Target | Roth Capital | Neutral | $70.00 to $67.00 |
| 2015-08-02 | Reiterated Rating | Oppenheimer | Buy | |
| 2015-07-31 | Boost Price Target | Oppenheimer | Outperform | $72.00 to $74.00 |
| 2015-07-15 | Boost Price Target | Roth Capital | Neutral | $60.00 to $70.00 |
| 2015-06-23 | Boost Price Target | Oppenheimer | Outperform | $61.00 to $67.00 |
| 2015-05-18 | Set Price Target | Roth Capital | Hold | $78.00 to $60.00 |
| 2015-05-06 | Lower Price Target | Oppenheimer | Outperform | $69.00 to $61.00 |
| 2015-04-10 | Downgrade | Roth Capital | Buy to Neutral | $78.00 |
| 2015-03-06 | Set Price Target | Guggenheim | Buy | $79.00 |
| 2015-02-27 | Set Price Target | Roth Capital | Buy | $65.00 to $78.00 |
| 2015-02-26 | Set Price Target | Roth Capital | Buy | $78.00 |
| 2015-02-19 | Set Price Target | Roth Capital | Buy | $65.00 to $78.00 |
| 2015-02-19 | Set Price Target | Guggenheim | Buy | $79.00 |
| 2015-02-18 | Boost Price Target | Oppenheimer | Outperform | $58.00 to $69.00 |
| 2014-12-15 | Initiated Coverage | Guggenheim | Buy | $65.00 |
| 2014-11-20 | Reiterated | ROTH Capital | Buy | $55 to $65 |
| 2014-11-20 | Boost Price Target | Roth Capital | Buy | $55.00 to $65.00 |
| 2014-08-05 | Boost Price Target | Oppenheimer | $35.00 to $37.00 | |
| 2014-07-31 | Reiterated Rating | Oppenheimer | Outperform | $40.00 to $35.00 |
| 2014-05-06 | Boost Price Target | Roth Capital | $36.00 to $38.00 | |
| 2014-03-06 | Boost Price Target | Oppenheimer | Outperform | $31.00 to $40.00 |
| 2014-02-20 | Boost Price Target | Roth Capital | $27.00 to $33.00 | |
| 2014-02-19 | Boost Price Target | Oppenheimer | Outperform | $29.00 to $31.00 |
| 2014-01-22 | Initiated Coverage | Oppenheimer | Outperform | $29.00 |
| 2014-01-07 | Initiated Coverage | Roth Capital | Buy | $27.00 |
| 2016-07-10 | Downgrade | Oppenheimer Holdings Inc. | Outperform | |
| 2016-07-08 | Downgrade | Citigroup Inc. | Outperform to Market Perform | $49.00 |
| 2016-06-22 | Initiated Coverage | Raymond James | Strong-Buy | $68.00 |
| 2016-06-22 | Initiated Coverage | Raymond James Financial Inc. | Strong-Buy | $68.00 |
| 2016-06-17 | Reiterated Rating | Guggenheim | Buy | $55.00 to $65.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In ANIP 110 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| BlackRock Inc. | 1.93M |
| BlackRock Fund Advisors | 0.79M |
| Vanguard Group, Inc | 0.79M |
| DIMENSIONAL FUND ADVISORS LP | 0.53M |
| EMERALD ADVISERS INC/PA | 0.46M |
| STATE STREET CORP | 0.45M |
| Global Alpha Capital Management Ltd. | 0.42M |
| THOMPSON SIEGEL & WALMSLEY LLC | 0.42M |
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | 0.37M |
| INVESTMENT COUNSELORS OF MARYLAND LLC | 0.35M |
| KENNEDY CAPITAL MANAGEMENT, INC. | 0.34M |
| EMERALD MUTUAL FUND ADVISERS TRUST | 0.34M |
| AMERIPRISE FINANCIAL INC | 0.31M |
| GEODE CAPITAL MANAGEMENT, LLC | 0.23M |
| BlackRock Institutional Trust Company, N.A. | 0.21M |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| MERIDIAN VENTURE PARTNERS II LP | 21636.22% (2350559) | ANIP / |
| MARSHBANKS TRACY | 4147.65% (450601) | ANIP / |
| RAYNOR DANIEL | 2660.19% (289003) | ANIP / |
| PRZYBYL ARTHUR President and CEO | 1920.39% (208631) | ANIP / |
| Marken James G. Vice President, Operations | 638.19% (69333) | ANIP / |
| Arnold Charlotte C. Chief Financial Officer | 499.80% (54298) | ANIP / |
| Jamnick Robert J. VP, Quality & Product Develop. | 442.91% (48118) | ANIP / |
| MANGANO ROSS J | 247.74% (26914) | ANIP / |
| Schrepfer Robert W VP Bus Dev & Con Mfg | 181.83% (19754) | ANIP / |
| Brown Robert E. JR | 152.50% (16568) | ANIP / |
| HOLUBOW FRED | 136.33% (14811) | ANIP / |
| CAREY STEPHEN P. Vice President and CFO | 129.95% (14118) | ANIP / |
| Penn Thomas A. | 102.26% (11110) | ANIP / |
| LANKAU PETER A | 23.01% (2500) | ANIP / |
UM